Market Cap 297.81M
Revenue (ttm) 0.00
Net Income (ttm) -55.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 5.49
Profit Margin 0.00%
Debt to Equity Ratio 0.31
Volume 436,400
Avg Vol 1,065,502
Day's Range N/A - N/A
Shares Out 60.16M
Stochastic %K 5%
Beta 0.98
Analysts Strong Sell
Price Target $9.00

Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator th...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 761 4904
Fax: 339 674 6495
Address:
131 Hartwell Avenue, Suite 320, Lexington, United States
Johnnyb11
Johnnyb11 Feb. 23 at 7:35 PM
$ALDX any news here?
1 · Reply
Aksunbay
Aksunbay Feb. 23 at 6:09 PM
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 22 at 10:57 PM
$ALDX Share Price: $4.94 Contract Selected: Sep 18, 2026 $5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.74 – $0.91 Potential Upside: 65% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 9:00 PM
$ALDX RSI: 37.72, MACD: 0.0431 Vol: 0.18, MA20: 5.29, MA50: 4.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BioSpecialOne
BioSpecialOne Feb. 22 at 7:21 AM
$ALDX Most retail traders look at the daily chart and see dead money, stuck in a tight channel since July. But if you look under the hood, the options market is telling a completely different story. IV Rank is currently sitting at 98%. The options chain is a coiled spring, pricing in an absolute volcano ahead of the March 16 PDUFA. The play here isn't to buy option. Entry zone: $4.85 - $5.05 Hard stop: $4.35 Take Profit: $6.20 - $6.40. Why here? SEC filings show an active $75M ATM offering. Management will likely use this run-up liquidity to raise cash, creating a massive resistance wall. We take our profits right before they tap the keg. Disclaimer: This is not financial advice or a recommendation to buy/sell. I am simply sharing my personal trade plan and mechanics for this specific setup.
0 · Reply
Moneymachineuser
Moneymachineuser Feb. 22 at 1:17 AM
$ALDX Todd is like Epstein
0 · Reply
User123321
User123321 Feb. 21 at 1:38 AM
$ALDX so either way we’ll have a great reason to drink. 😂
1 · Reply
History101
History101 Feb. 21 at 12:41 AM
$ALDX extended PDUFA due Monday, March 16, 2026, the day before St Patricks day
0 · Reply
Moneymachineuser
Moneymachineuser Feb. 20 at 8:57 PM
$ALDX i will buy back in again in the 1's
3 · Reply
Aksunbay
Aksunbay Feb. 20 at 7:59 PM
$ALDX Only three weeks left until approval, stay strong. Lock up your shares and just wait it out. Don't give Steven a chance.
0 · Reply
Latest News on ALDX
Johnnyb11
Johnnyb11 Feb. 23 at 7:35 PM
$ALDX any news here?
1 · Reply
Aksunbay
Aksunbay Feb. 23 at 6:09 PM
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 22 at 10:57 PM
$ALDX Share Price: $4.94 Contract Selected: Sep 18, 2026 $5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.74 – $0.91 Potential Upside: 65% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 9:00 PM
$ALDX RSI: 37.72, MACD: 0.0431 Vol: 0.18, MA20: 5.29, MA50: 4.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BioSpecialOne
BioSpecialOne Feb. 22 at 7:21 AM
$ALDX Most retail traders look at the daily chart and see dead money, stuck in a tight channel since July. But if you look under the hood, the options market is telling a completely different story. IV Rank is currently sitting at 98%. The options chain is a coiled spring, pricing in an absolute volcano ahead of the March 16 PDUFA. The play here isn't to buy option. Entry zone: $4.85 - $5.05 Hard stop: $4.35 Take Profit: $6.20 - $6.40. Why here? SEC filings show an active $75M ATM offering. Management will likely use this run-up liquidity to raise cash, creating a massive resistance wall. We take our profits right before they tap the keg. Disclaimer: This is not financial advice or a recommendation to buy/sell. I am simply sharing my personal trade plan and mechanics for this specific setup.
0 · Reply
Moneymachineuser
Moneymachineuser Feb. 22 at 1:17 AM
$ALDX Todd is like Epstein
0 · Reply
User123321
User123321 Feb. 21 at 1:38 AM
$ALDX so either way we’ll have a great reason to drink. 😂
1 · Reply
History101
History101 Feb. 21 at 12:41 AM
$ALDX extended PDUFA due Monday, March 16, 2026, the day before St Patricks day
0 · Reply
Moneymachineuser
Moneymachineuser Feb. 20 at 8:57 PM
$ALDX i will buy back in again in the 1's
3 · Reply
Aksunbay
Aksunbay Feb. 20 at 7:59 PM
$ALDX Only three weeks left until approval, stay strong. Lock up your shares and just wait it out. Don't give Steven a chance.
0 · Reply
Moneymachineuser
Moneymachineuser Feb. 20 at 5:34 PM
$ALDX cooked!!!
1 · Reply
BilboBagginses
BilboBagginses Feb. 20 at 3:20 PM
$ALDX https://www.nejm.org/doi/full/10.1056/NEJMsb2517623 "new FDA policy that the default requirement for FDA approvals will be one robust pivotal trial plus confirmatory evidence, rather than two trials." All of a sudden I'm starting to have more confidence, I think this will now be more down to labelling,
1 · Reply
All4Retiring
All4Retiring Feb. 20 at 3:09 PM
$ALDX How many of these recently purchased puts will expire worthless today?
2 · Reply
Aksunbay
Aksunbay Feb. 20 at 2:35 PM
0 · Reply
whatabigcockyouhave
whatabigcockyouhave Feb. 19 at 11:26 PM
$ALDX reminds me of ATYR
1 · Reply
philipv777
philipv777 Feb. 19 at 10:08 PM
$ALDX no idea what’s going to happen This has not gone as I expected 4x now. I place no significance to the upcoming meeting, all it tells me is Todd is positive and he either knows something or most likely hasn’t heard from fda yet. And that carries little weight given the past. ABBV not walking is nice but as many have noted they’ve bet peanuts; and why would they walk when they can just wait? My tilt is still positive as I interpret the events. The FDA is ultimately the authority on deciding whether a drug is efficacious enough to be marketed to the American public and the drafting of the label is the strongest evidence of their intention. And each division is tasked with this decision, not the OSM (but of course nothing happens until they sign off). Also nice to see price holding despite all the negativity and skepticism.
4 · Reply
GoldmanSlaps
GoldmanSlaps Feb. 19 at 10:00 PM
$ALDX some interesting prints at the close much larger than usual
0 · Reply
RoyBasch
RoyBasch Feb. 19 at 6:36 PM
$ALDX Timeline matters. FDA label communication was indicated for Feb 16. US markets were closed for Presidents’ Day, so any formal update would realistically shift to Feb 17. On Feb 18 (pre-market), Aldeyra announced participation in the Oppenheimer conference next week. Think about the sequence. If the company had received an unexpected negative signal, it would be highly unlikely to step into a public investor forum immediately after. Management teams don’t voluntarily put themselves in front of analysts during uncertainty. The timing suggests they likely received either the expected feedback or constructive clarity from the FDA. Otherwise, participation in a visible healthcare conference would make little strategic sense. Things are looking good 👍🏼
1 · Reply
badgermobile
badgermobile Feb. 19 at 11:26 AM
$ALDX How about all the Idiots spewing needs two drug tests for approval well sorry about your complaints apnews.com/article/fda-drug... FDA will drop two-study requirement for new drug approvals, aiming to speed access https://apnews.com
2 · Reply
whatabigcockyouhave
whatabigcockyouhave Feb. 19 at 2:45 AM
$ALDX it’s going to be great seeing this below $1
1 · Reply
Moneymachineuser
Moneymachineuser Feb. 19 at 1:11 AM
$ALDX ceo is really good at letting retailers down 👇🏻
2 · Reply
RigidFlexibility
RigidFlexibility Feb. 18 at 9:49 PM
$ALDX ….wow, lots of negative analysis and people foaming at their keyboards all of a sudden. I just think no one knows what’s really going to happen here. My bet is on black. Staying long and strong. Its just money. GLTA.
2 · Reply